Contact Supplier

Contact Supplier

To get in touch with ARTES Biotechnology GmbH, simply fill out the form below.

Subscribe to Supplier

Subscribe to Supplier

.
“Never again 2020: Let’s get vaccinated” – “Initiative against Corona” calls for vaccinations

ARTES Biotechnology GmbH News Releases

Find the latest News from ARTES Biotechnology GmbH

Page 1 of 3
“Never again 2020: Let’s get vaccinated” – “Initiative against Corona” calls for vaccinations
“Never again 2020: Let’s get vaccinated” – “Initiative against Corona” calls for vaccinations Learn More >
ARTES is convinced: defeating SARS COVID-19 will require different vaccines
ARTES is convinced: defeating SARS COVID-19 will require different vaccines Learn More >
Worldwide, researchers work on a coronavirus vaccine
Worldwide, researchers work on a coronavirus vaccine Learn More >
ARTES joins global CV-19 combat with VLP vaccine candidates
ARTES joins global CV-19 combat with VLP vaccine candidates Learn More >
France renews CIR tax credits for ARTES R&D services
France renews CIR tax credits for ARTES R&D services Learn More >
ARTES presenting opportunities for vaccine development at BIO-Europe Spring in Paris
ARTES presenting opportunities for vaccine development at BIO-Europe Spring in Paris Learn More >
Data on production and immunogenicity of malaria transmission-blocking vaccine candidates published by ARTES and Burnet Institute
Data on production and immunogenicity of malaria transmission-blocking vaccine candidates published by ARTES and Burnet Institute Learn More >
ARTES presenting new development offer at BIOEurope Spring in Vienna
ARTES presenting new development offer at BIOEurope Spring in Vienna Learn More >
ARTES adds SplitCore technology to vaccine development portfolio
ARTES adds SplitCore technology to vaccine development portfolio Learn More >
ARTES and Minapharm join forces to package biopharma solutions
ARTES and Minapharm join forces to package biopharma solutions Learn More >
ARTES successfully completes EU-funded project PLURIVAX
ARTES successfully completes EU-funded project PLURIVAX Learn More >
ARTES presenting protein production and vaccine development opportunities at BIO-Europe 2018
ARTES presenting protein production and vaccine development opportunities at BIO-Europe 2018 Learn More >
Page 1 of 3